No Data
No Data
JonesTrading Maintains Serina Therapeutics(SER.US) With Buy Rating, Maintains Target Price $11
Serina Therapeutics FY24 EPS $(1.51) Down From $0.73 YoY, Total Revenues $56K Down From $3.15M YoY
Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
Serina Therapeutics | 10-K: Annual report
Serina Therapeutics Unveils Breakthrough in POZ-Lipid Technology
Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting
Unlock the Full List